FDA Wants More Info on Avedro’s Corneal Cross-Linking NDA

Company chief executive officer is 'confident' the issues surrounding riboflavin ophthalmic solution/KXL System for keratoconus and corneal ectasia after refractive surgery can be resolved.
Medscape Medical News